Anixa Biosciences (ANIX) Other Non Operating Income (2011 - 2017)
Anixa Biosciences' (ANIX) quarterly Other Non Operating Income came in at $2.8 million in Q4 2017, up 81.14% on a QoQ basis from $1.5 million in Q2 2017.
Anixa Biosciences (ANIX) Other Non Operating Income (2011 - 2017) Analysis & Trends
Anixa Biosciences (ANIX) has 4 years of Other Non Operating Income data on file, last reported at $2.8 million in Q4 2017.
- Quarterly Other Non Operating Income changed N/A year-over-year to $2.8 million in Q4 2017, while the trailing twelve-month figure through Oct 2017 was $3.1 million (changed N/A YoY) and the FY2019 annual result came in at -$995000.0, up 17.5% from the prior year.
- Other Non Operating Income advanced to $2.8 million in Q4 2017, from $1.5 million in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $2.8 million in Q4 2017 to a low of -$1.3 million in Q1 2014.
- A 3-year average of $265996.9 and a median of $210000.0 in 2013 frame the typical range for Other Non Operating Income.
- The widest YoY moves for Other Non Operating Income: up 571.76% in 2014, down 571.76% in 2014.
- Tracing ANIX's Other Non Operating Income over 3 years: stood at $210000.0 in 2013, then slumped by 689.68% to -$1.2 million in 2014, then soared by 326.39% to $2.8 million in 2017.
- The last three Other Non Operating Income figures came in at $2.8 million (Q4 2017), $1.5 million (Q2 2017), and -$1.2 million (Q4 2014), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Anixa Biosciences | 123.62 Mn | 123.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2017 | 2.80 Mn |
| Apr 30, 2017 | 1.55 Mn |
| Oct 31, 2014 | -1.24 Mn |
| Jul 31, 2014 | 850,000.00 |
| Apr 30, 2014 | -990,704.00 |
| Jan 31, 2014 | -1.32 Mn |
| Apr 30, 2013 | 210,000.00 |
| Oct 31, 2011 | -43,507.00 |
| Jul 31, 2011 | 33,507.00 |